Latest news and articles about Mounjaro from NEX English
French Health Minister Stéphanie Rist has announced that reimbursements for obesity treatment using the drugs <strong>Wegovy</strong> and <strong>Mounjaro</strong> will begin in mid-June. This initiative targets patients suffering from severe obesity and aims to mitigate potential health risks.
A recent study has revealed that specific genes play a crucial role in the success of weight loss injections like Wegovy and Mounjaro, with varying results and side effects among individuals. This highlights the importance of genetic factors in weight management treatments.
A recent study indicates that individuals with specific genetic mutations can achieve greater weight loss when using medications like Wegovy and Mounjaro. These findings may explain the significant differences in drug efficacy among individuals.